SCM
CELG

Stonebridge Capital Management’s Celgene Corp CELG Stock Holding History

Stonebridge Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,098
Closed -$208K – 118
2019
Q3 		$208K Buy
+2,098
New +$199K 0.1% 108
2019
Q2 		– Sell
-2,132
Closed -$201K – 151
2019
Q1 		$201K Buy
+2,132
New +$186K 0.07% 131
2018
Q1 		– Sell
-2,098
Closed -$222K – 142
2017
Q4 		$222K Hold
2,098
– – 0.08% 120
2017
Q3 		$306K Sell
2,098
-100
-5% -$13.6K 0.12% 107
2017
Q2 		$285K Hold
2,198
– – 0.11% 109
2017
Q1 		$273K Hold
2,198
– – 0.11% 102
2016
Q4 		$254K Hold
2,198
– – 0.11% 99
2016
Q3 		$230K Buy
+2,198
New +$238K 0.1% 103
2016
Q2 		– Sell
-2,000
Closed -$200K – 157
2016
Q1 		$200K Hold
2,000
– – 0.09% 146
2015
Q4 		$240K Hold
2,000
– – 0.1% 141
2015
Q3 		$216K Hold
2,000
– – 0.1% 142
2015
Q2 		$231K Hold
2,000
– – 0.09% 142
2015
Q1 		$231K Hold
2,000
– – 0.09% 147
2014
Q4 		$224K Buy
+2,000
New +$211K 0.09% 161

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Stonebridge Capital Management's CELG Position: Q4 2019 in Review

Stonebridge Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,098 shares — an estimated $208K sold.

Stonebridge Capital Management first reported a position in CELG in Q4 2014 and held it in 14 quarters. The position peaked at $306K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Stonebridge Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Stonebridge Capital Management sold 2,098 Celgene Corp shares in Q4 2019, an estimated $208K.
  • Stonebridge Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 14 quarters.
  • Stonebridge Capital Management's Celgene Corp position peaked at $306K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Stonebridge Capital Management's 13F filing for Q4 2019, filed 2 Jan 2020.